NasdaqGS:RPRXPharmaceuticals
Royalty Pharma (NasdaqGS:RPRX) Declares US$0.22 Dividend for Q2 2025
Royalty Pharma (NasdaqGS:RPRX) recently affirmed its dividend, setting it at $0.22 per Class A ordinary share for the second quarter of 2025, demonstrating its financial stability and commitment to shareholders. The appointment of Vlad Coric to the board, who brings significant expertise in drug development, may further reinforce investor confidence. The company's share price increased by 7% over the last quarter, aligning well with the broader market's recovery as major indices like the Dow...